Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
27.98
+1.15 (4.29%)
At close: Nov 6, 2026, 4:00 PM EST
27.51
-0.47 (-1.68%)
After-hours: Nov 6, 2026, 7:30 PM EST

Adaptive Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,5292,4798857091,0933,960
Market Cap Growth
68.67%180.23%24.72%-35.07%-72.41%-51.03%
Enterprise Value
4,5382,4768425697983,441
Last Close Price
27.9816.246.004.907.6428.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
15.208.954.944.175.9025.66
PB Ratio
25.6511.024.372.302.356.56
P/TBV Ratio
79.7625.2711.023.853.238.31

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
15.238.944.703.344.3122.29

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.220.941.100.740.500.19
Net Debt / Equity Ratio
0.05-0.13-0.16-0.38-0.57-0.76
Net Debt / EBITDA Ratio
-0.270.760.250.651.482.35
Net Debt / FCF Ratio
-1.000.610.340.701.321.80
Asset Turnover
0.510.530.300.220.210.15
Inventory Turnover
16.0318.0915.3013.6811.8411.50
Quick Ratio
3.723.102.714.384.913.27
Current Ratio
3.973.342.894.665.123.54
Return on Equity (ROE)
-36.45%-27.82%-62.49%-58.34%-37.52%-30.77%
Return on Assets (ROA)
-5.13%-6.79%-16.18%-16.60%-14.06%-12.81%
Return on Capital Employed (ROCE)
-8.30%-13.50%-35.20%-35.20%-26.80%-25.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.62%-2.40%-18.03%-31.75%-18.32%-5.23%
FCF Yield
-0.19%-1.97%-11.18%-23.54%-18.33%-6.43%
Buyback Yield / Dilution
-4.58%-3.14%-1.88%-1.31%-1.54%-6.96%
SEC Filings: 10-K · 10-Q